Find your test
Longevity Lab
Your blood, understood

A closer look.
A clearer you.

Private blood testing, personal insight and expert guidance. Start with what matters to you.

Find your test

How we run our business

Our responsibilities

Clear health information. Respect for people. Care in the choices we make.

These commitments apply to Vitality Consult Ltd, trading as The Longevity Lab, including our testing, wellness consultancy and occupational health services.

Approved by Matthew William James Baker, sole director, on 20 November 2026. Next annual review: 20 November 2027.

Our purpose

We help people understand their health information and make informed decisions about their wellbeing through clear, responsible and personalised services. We aim to create a material positive impact on people and the environment by improving understanding, respecting individual choice and privacy, and reducing avoidable harm and waste in how our services are delivered.

When we choose laboratories, set prices, change services or make significant purchases, we consider the effects on clients, people assessed through occupational health services, suppliers and their workers, communities and the environment, alongside the company’s financial position. Matthew is accountable for these decisions.

We explain a service’s purpose, limitations, price and relevant alternatives before purchase. We do not use fear or exaggerated certainty to sell tests or supplements. Personal information belongs in secure systems, and we do not use identifiable health information in marketing or supplier reviews. Our privacy notice explains how we handle information.

We record relevant business and personal interests in purchasing or referral decisions, consider reasonable alternatives and explain our choices. Commercial or affiliate relationships must be disclosed near the relevant recommendation.

People and responsible purchasing

We commit to respecting internationally recognised human rights in our activities and purchasing decisions, informed by the UN Guiding Principles on Business and Human Rights. We will not knowingly benefit from forced labour, child labour, discrimination, unsafe working conditions or interference with lawful worker representation.

Before appointing or renewing a material supplier, we assess the service, relevant locations, labour conditions, client safety, privacy, environmental effects and any credible concerns. We apply greater scrutiny where the product, material, country or workforce conditions create a higher risk. Price and turnaround time do not justify overlooking serious harm.

Where a concern arises, we prioritise its severity, seek information safely and agree corrective action with dates and evidence. Where we caused or contributed to harm, we cooperate in providing or enabling a remedy. We pause work where an immediate serious risk cannot be controlled and consider the effects on people before ending a relationship.

We agree realistic specifications and payment terms, pay valid invoices as agreed, and avoid changes that pressure suppliers into unsafe or unfair practices. We review higher-risk suppliers at least annually and other material suppliers at renewal or after a significant concern.

Equality and inclusion

The Longevity Lab commits to operating in a just, equitable, diverse and inclusive manner across its business, services, customer relationships and community activities. We will identify unfair barriers, treat people with dignity and make reasonable changes that help people understand and access our services.

Matthew William James Baker, sole director of Vitality Consult Ltd, is responsible for approving and overseeing this commitment, applying it in decisions and responding when people report exclusion or unfair treatment.

  • Use plain language to explain services, results and limitations. Offer an appropriate alternative to a purely digital interaction when someone needs support.
  • Ask what assistance is needed without requiring unnecessary sensitive information. Record agreed adjustments securely.
  • Use respectful communications and avoid assumptions about a person’s health needs, identity or circumstances.
  • Base test eligibility and interpretation on clinically relevant information and explain why necessary questions are asked.
  • Consider cost, disability, digital access and language barriers when changing the client experience, and seek feedback from people affected.
  • Assess suppliers and any future recruitment fairly. Do not tolerate discrimination or degrading conduct.

By 31 January 2027, we will review our enquiry, ordering, result-delivery and complaints routes for practical access barriers, record findings and prioritise changes. If you need another format or help accessing a service, contact us. Concerns can also be raised through our complaints procedure.

Environmental policy

We will reduce avoidable environmental harm from our office, purchasing and service supply chain. Our first priorities are laboratory services, sample transport, kits and packaging, business travel, energy and electronic equipment. Clinical safety, sample integrity and accessibility remain essential.

  • Use remote administration and suitable remote consultations to avoid unnecessary travel.
  • Provide reports digitally by default, with paper or another format available where needed.
  • Use equipment for its useful life, repair where feasible, consider suitable refurbished replacements and recycle electronics and batteries appropriately.
  • Work with suppliers to reduce unnecessary packaging and inserts. Never reuse single-use clinical items or remove packaging needed for safe transport.
  • Follow laboratory and collection-provider procedures for sharps, samples and clinical waste. Keep them out of domestic recycling.

We consider energy, transport, waste and avoidable repeat sampling when reviewing suppliers. We record the method and reporting period behind any environmental figures and keep estimates separate from measurements.

Climate action plan

We commit to supporting the global ambition to limit warming to 1.5°C. This first plan addresses likely emissions from bought-in laboratory services, kits, deliveries, travel, office energy and equipment. We have not yet measured the relative size of these sources or established a company carbon footprint.

Matthew owns every action below. He will reserve at least one hour each month for implementation and a quarterly review, use existing records where possible and record spending decisions before committing funds.

Supplier coverage By 31 January 2027
Identify suppliers covering at least 80% of annual purchasing spend using the latest full-year records. Review available climate, packaging and transport evidence for each, and record gaps and requests.
Purchasing decisions By 30 April 2027
For 100% of new or renewed material laboratory, kit and collection arrangements from adoption, record lower-emission options, the choice and any safety constraints.
Avoidable travel By 30 April 2027
Offer a remote option for 100% of consultations suitable for remote delivery. Record exceptions and business journeys to identify avoidable travel.
Paper and equipment By 31 January 2027
Make digital reports the default for all new clients, with accessible alternatives. Check repair or suitable refurbished options for every equipment replacement.
Office energy By 30 April 2027
Review the electricity tariff and operating settings by 31 January 2027. Implement the feasible lower-emission option and power-saving settings, documenting household or tenancy constraints and a reasonable allocation of business energy use.
Progress and reporting Quarterly and annually
Track each measure quarterly, with the first review by 28 February 2027. Publish an annual update by 20 November 2027, including missed targets, limitations and revised actions.

These are commitments, not reported achievements. We will retain the evidence and denominator behind each measure. A request for information is not a verified emissions reduction. We will not claim a quantified saving without a defensible baseline and method or substitute unverified offsets for reductions.

We invite feedback on this plan and will review it at least annually. Cost, accessibility, clinical safety and the effects on suppliers will inform changes to delivery methods.

Responsible influence and collective action

Any business activity intended to influence public decisions, directly or through a consultant, trade body or other intermediary, must support positive social or environmental outcomes and be consistent with these policies. Positions must be supported by reliable evidence, with uncertainty and commercial interests explained.

Matthew must approve the purpose, position, evidence, recipients, budget and any intermediary before activity begins. We keep a register of contacts, positions, contributions and outcomes, and review memberships and intermediary positions at least annually. We will challenge material conflicts and record whether to correct them, withdraw support or leave.

Company donations to political parties or candidates are prohibited under this policy. We do not offer payments or benefits to secure influence. Personal political activity must remain separate from the business and must not use company funds, client information or implied company endorsement.

Before advocacy, we check conflicts, human-rights and reputational risks, climate consistency and the accuracy of public claims. We will publish a transparent annual record of relevant activity and contributions after checking our records.

Our planned collective action is to work with a local community organisation or independent practitioner on an accessible educational session or resource about understanding blood-testing information and the limits of screening. We aim to agree a suitable partner and purpose by 31 January 2027 and complete one activity by 30 April 2027. This activity is planned and has not yet been delivered. It must provide a public or social benefit beyond promoting our services.

Listening and accountability

We invite feedback from clients, suppliers and other people affected by our work. Feedback does not depend on making a purchase or leaving a positive review. Matthew reviews concerns, supplier information, climate actions and feedback quarterly and records the changes, owners and due dates.

Anyone affected by our business can raise a complaint or concern free of charge and without retaliation. We consider anonymous concerns and requests for confidentiality or a different communication format.

These policies were adopted on 20 November 2026. We will report actual progress separately from intentions. The Longevity Lab is not currently a Certified B Corporation.